Skin Findings in 121 Athletes Versus 121 Sedentary Controls
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured scene is an AI-created illustration of a fictional work, activity or research setting. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
The question behind this paper
This review looks at sports participation, friction, moisture and skin screening. The aim is to preserve the study’s actual population, denominator, design and timepoint so a useful signal does not become a universal claim.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 121 licensed athletes—42 swimmers, 23 handball players, 33 soccer players and 23 wrestlers—and 121 sedentary controls |
| Design | Cross-sectional dermatologist-examination study |
| Timepoint | Single clinical evaluation with sport duration and lesion localization recorded |
| Key result | Traumatic lesions were frequent in soccer players and wrestlers, while fungal infections were more common in swimmers and soccer players; viral and bacterial lesion incidence did not differ significantly by sport type. |
How to interpret the result
Different sports showed different lesion patterns, but the findings cannot prove that participation caused every lesion. The null viral and bacterial comparisons are important counterweights to the positive patterns.
Important limitation: The study was cross-sectional, subgroup sizes were small, many lesion counts were not reported in the abstract, and it was not an eczema-treatment study.
Questionnaires, examinations, patch tests, chemical analyses and trial models answer different questions. A positive screening result, symptom report or association can guide a next step, but it does not diagnose the cause of one person’s rash. Clinician-directed testing is interpreted alongside timing, distribution and verified exposures.
Questions to ask next
- What exactly was measured: reported symptoms, visible signs, allergy, work loss, performance or quality of life?
- Which denominator applies to the quoted percentage: everyone invited, respondents, symptomatic people, examined participants or a selectively tested subgroup?
- Did the design compare groups or follow change over time, and what factors could still explain the difference?
- Would occupational-health review, clinician examination or clinician-directed testing change the practical plan?
- What requires prompt medical evaluation, including rapidly spreading redness, drainage, fever, severe pain, breathing symptoms or major loss of function?
Primary and authoritative sources
- Primary medical research record: PubMed PMID 16334860
- Authoritative guidance relevant to this topic
- American Academy of Dermatology: eczema skin-care guidance
PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.
Where a cosmetic moisturizer fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.
Bottom line
The responsible conclusion is narrow: keep the population, denominator, comparator, timepoint and limitations attached, then use the evidence to ask better clinical and exposure-control questions rather than promise a universal result.